IgG4-related disease: a review with an Indian perspective

Authors

  • Lalit Duggal Department of Rheumatology and Clinical Immunology, Sir Ganga Ram Hospital, NCR, Delhi, India
  • Neeraj Jain Department of Rheumatology and Clinical Immunology, Sir Ganga Ram Hospital, NCR, Delhi, India
  • Bhandari Gurbir Singh Department of Rheumatology and Clinical Immunology, Sir Ganga Ram Hospital, NCR, Delhi, India
  • Jeet Hemant Kumar Patel Department of Rheumatology and Clinical Immunology, Sir Ganga Ram Hospital, NCR, Delhi, India
  • Vishal Goyal Janssen Johnson and Johnson Private Limited, India
  • Disha Gupta Janssen Johnson and Johnson Private Limited, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20213436

Keywords:

Epidemiology, IgG, IgG4-related diseases, India, Treatment practices

Abstract

IgG4-related disease (IgG4-RD) is a recently discovered (2003) complex disease, manifesting in various organs with symptoms mimicking other diseases. Progression of the disease leads to organ failure and hence early diagnosis is an urgent requirement in these patients. There is scarcity in reporting of IgG4-RD globally and in India. The aim of the study was to generate awareness on the epidemiology, diagnosis, and practice trends for IgG4-RD in India and globally, and to aid Indian physicians in early diagnosis of IgG4-RD in patients. Additionally, the evidence currently available in the Indian subpopulation has been evaluated. A preliminary literature search was performed using the PubMed database with the keywords including ‘IgG4-related disease’ in the title and abstract to obtain the relevant data. In total, PubMed identified 2071 publications comprising world-wide studies published in the English language before 30 April 2021. Studies were filtered region-wise by adding ‘India’ to the search strategy and total 60 publications were identified. The relative newness of IgG4-RD and the ensuing paucity in literature limits diagnosis by clinicians. Awareness of the disease among Indian clinicians would improve understanding of the disease and development of a country-specific consensus-based management guideline might lead to better prognosis in Indian patients with IgG4-RD.

References

Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460-71.

Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine. 2015;94(15):680.

Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22(1):1-14.

Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466-75.

Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061-7.

Lang D, Zwerina J, Pieringer H. IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag. 2016;12:189-99.

Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181(2):191-206.

Okazaki K, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, et al. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2014;49(4):567-88.

Okazaki K, Uchida K. Current perspectives on autoimmune pancreatitis and IgG4-related disease. Proc Jpn Acad Ser B Phys Biol Sci. 2018;94(10):412-27.

Tanaka A. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis. Gut Liver. 2019;13(3):300-7.

Takano K, Nomura K, Abe A, Kamekura R, Yamamoto M, Ichimiya S, et al. Clinicopathological analysis of salivary gland tissue from patients with IgG4-related disease. Acta Otolaryngol. 2016;136(7):717-21.

Aboulenain S, Miquel TP, Maya JJ. Immunoglobulin G4 (IgG4)-Related Sialadenitis and Dacryoadenitis With Chronic Rhinosinusitis. Cureus. 2020;12(8):9756.

Khosroshahi A, Carruthers MN, Stone JH, Shinagare S, Sainani N, Hasserjian RP, et al. Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease. Medicine. 2013;92(2):82-91.

Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33(12):1833-9.

Wang K, Wang Z, Zeng Q, Zhu L, Gao J, Wang Z, et al. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. PLoS One. 2021;16(2):245601.

Floreani A, Okazaki K, Uchida K, Gershwin ME. IgG4-related disease: Changing epidemiology and new thoughts on a multisystem disease. J Transl Autoimmun. 2020;4:100074.

Leporati P, Salgado MA, Lupi I, Chiovato L, Caturegli P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab. 2011;96(7):1971-80.

Chen H, Lin W, Wang Q, Wu Q, Wang L, Fei Y, et al. IgG4-related disease in a Chinese cohort: a prospective study. Scand J Rheumatol. 2014;43(1):70-4.

Ebbo M, Daniel L, Pavic M, Sève P, Hamidou M, Andres E, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine. 2012;91(1):49-56.

Das D, Deka P, Verma G, Kuri GC, Bhattacharjee H, Bharali G, Pandey D, et al. IgG4-related intraocular inflammation masquerading as ciliary body melanoma in a young girl. Indian J Ophthalmol. 2016;64(8):601-3.

Mahajan MS, Maitra S, Singh N, Pereira M. IgG4-related disease simulating paraneoplastic syndrome: role of 18 FDG PET/CT imaging. Indian J Radiol Imaging. 2017;27(2):249-53.

Ramadass T, Balaji V, Sheba SKJ, Vali Ahmed KS, Abdurahiman R. IgG4-related disease (IgG4-RD) presenting as a mass in the carotid triangle masquerading paraganglioma. Indian J Otolaryngol Head Neck Surg. 2017;69(2):259-62.

Rastogi A, Bihari C, Grover S, Rajbongshi A, Arora A, Nikhil N, et al. Hepatobiliary IgG4 cholangiopathy: case Series and literature review. Int J Surg Pathol. 2015;23(7):531-6.

Vadi SK, Parihar AS, Kumar R, Singh H, Mittal BR, Bal A, et al. IgG4-related disease simulating carcinoma colon with diffuse peritoneal carcinomatosis on 18F-FDG PET/CT. Clin Nucl Med. 2018;43(7):247-9.

Yadav KS, Sali PA, Mansukhani VM, Shah R, Jagannath P. IgG4-associated sclerosing cholangitis masquerading as hilar cholangiocarcinoma. Indian J Gastroenterol. 2016;35(4):315-8.

Gupta N, Mathew J, Mohan H, Chowdhury SD, Kurien RT, Christopher DJ, et al. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India. Rheumatol Int. 2018;38(2):203-9.

Duggal L, Singh BG, Patel J, Gupta M, Grover AK, Jain N. IgG4-Related Disease: A Clinical Case Series From a Tertiary Care Center in India. J Clin Rheumatol. 2020.

Karim F, Loeffen J, Bramer W, Westenberg L, Verdijk R, Hagen M, et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J. 2016;14(1):18.

Prabhu SM, Yadav V, Irodi A, Mani S, Varghese AM. IgG4-related disease with sinonasal involvement: A case series. Indian J Radiol Imaging. 2014;24(2):117-20.

Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181-92.

Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67(7):1688-99.

Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology/European League against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79(1):77-87.

Ebbo M, Grados A, Bernit E, Vely F, Boucraut J, Harle JR, et al. Pathologies associated with serum IgG4 elevation. Int J Rheumatol. 2012;602809.

Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21-30.

Shimizu Y, Yamamoto M, Naishiro Y, Sudoh G, Ishigami K, Yajima H, Tabeya T, et al. Necessity of early intervention for IgG4-related disease--delayed treatment induces fibrosis progression. Rheumatology. 2013;52(4):679-83.

Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della TE, Lee H, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190-5.

Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD Responder Index. Int J Rheumatol. 2012;259408.

Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, et al. An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index. Arthritis Care Res (Hoboken). 2018;70(11):1671-8.

Yamamoto M. B cell targeted therapy for immunoglobulin G4-related disease. Immunol Med. 2021.

Anandh U, Virarkar M, Shah A, Hastak M. Immunoglobin G4-related disease: Two case reports and review of the recent literature. Saudi J Kidney Dis Transpl. 2015;26(6):1282-8.

Chougule A, Bal A, Das A, Agarwal R, Singh N, Rao KL. A comparative study of inflammatory myofibroblastic tumors and tumefactive IgG4-related inflammatory lesions: the relevance of IgG4 plasma cells. Appl Immunohistochem Mol Morphol. 2016;24(10):721-8.

Dutta D, Ahuja A, Selvan C. Immunoglobulin G4 related thyroid disorders: Diagnostic challenges and clinical outcomes. Endokrynol Pol. 2016;67(5):520-4.

Jain V, Pandey PK, Bihari C. Steroid-responsive IgG4-related disease with isolated prostatic involvement: an unusual presentation with elevated serum PSA. Indian J Urol. 2016;32(2):166-8.

Kurien AA, Raychaudhury A, Walker PD. Membranous nephropathy as a rare renal manifestation of IgG4-related disease. Indian J Nephrol. 2015;25(3):164-7.

Mulay K, Aggarwal E, Jariwala M, Honavar SG. Orbital immunoglobulin-G4-related disease: case series and literature review. Clin Exp Ophthalmol. 2014;42(7):682-7.

Nithyashree N, Rajagopalan S, Annigeri RA, Mani R. Immunoglobulin G4 related tubulointerstitial nephritis. Indian J Nephrol. 2015;25(5):303-6.

Pradhan D, Pattnaik N, Silowash R, Mohanty SK. IgG4-related kidney disease-A review. Pathol Res Pract. 2015;211(10):707-11.

Radotra BD, Aggarwal A, Kapoor A, Singla N, Chatterjee D. An orphan disease: IgG4-related spinal pachymeningitis: report of 2 cases. J Neurosurg Spine. 2016;25(6):790-4.

Sharma P, Chatterjee P. Contrast-enhanced (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in immunoglobulin G4-related retroperitoneal fibrosis. Indian J Nucl Med. 2015;30(1):72-4.

Veerankutty FH, Saleem S, Chacko S, Sreekumar VI, Krishnan P, Varma D, et al. IgG4-related disease of the appendix. J Gastrointest Surg. 2018;22(6):1124-6.

Downloads

Published

2021-08-25

How to Cite

Duggal, L., Jain, N., Singh, B. G., Patel, J. H. K., Goyal, V., & Gupta, D. (2021). IgG4-related disease: a review with an Indian perspective. International Journal of Research in Medical Sciences, 9(9), 2877–2886. https://doi.org/10.18203/2320-6012.ijrms20213436

Issue

Section

Review Articles